CLOs on the Move

Ausepx Pharma

www.auspexpharma.com

 
Auspex Pharmaceuticals, Inc. develops deuterated analogs of clinically-validated drugs. Its technology replaces metabolically-sensitive hydrogen atoms with its non-radioactive isotope deuterium to create therapeutics. The company was founded in 2001 and is based in La Jolla, California.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Canadian Association of Gastroenterology

Canadian Association of Gastroenterology is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Unlock Health

Unlock Health Chiropractic is a natural medical service provider that offers long term solutions and overall wellness for families.

Quantum Group

Quantum Group is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Quantum Group is based in Wellington, FL. You can find more information on Quantum Group at www.quantummd.com

Care Rx Corporate Office

Care Rx Corporate Office is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.